Clinical Trial Update: Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing icotinib with concurrent radiotherapy versus chemoradiotherapy in non-small cell lung cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: People's Hospital of Guangxi Zhuang Autonomous Region | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN